| ANAVEX LIFE SCI. DL-,001 |
| USA |
| Gesundheit |
| US0327973006 / A1411S |
| 12X1 (Frankfurt) / AVXL (NASDAQ) |
| FRA:12X1, ETR:12X1, 12X1:GR, NASDAQ:AVXL |
| - |
| https://www.anavex.com/ |
|
Anavex Life Sciences Corp. is a biopharmaceutical ..
>Volltext.. |
| 265.34 Mio. EUR |
| 179.46 Mio. EUR |
| - |
| -47.37 Mio. EUR |
| -41.57 Mio. EUR |
| -0.49 EUR |
| - |
| 87.3 Mio. EUR |
| -32.01 Mio. EUR |
| 8.82 |
| - |
| -5.47% |
| - |
| - |
| - |
| - |
| ANAVEX |
| 19.11.25 |
|